This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1999 Jan 9;353(9147):117-8.

doi: 10.1016/S0140-6736(05)76153-5.

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma

P Maddison, J Newsom-Davis, K R Mills, R L Souhami

PMID: 10023900
DOI: 10.1016/S0140-6736(05)76153-5

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma

P Maddison et al. Lancet. 1999.

. 1999 Jan 9;353(9147):117-8.

doi: 10.1016/S0140-6736(05)76153-5.

Authors

P Maddison, J Newsom-Davis, K R Mills, R L Souhami

PMID: 10023900
DOI: 10.1016/S0140-6736(05)76153-5

No abstract available

PubMed Disclaimer

Similar articles

Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, Posner JB, Dalmau J. Mason WP, et al. Brain. 1997 Aug;120 ( Pt 8):1279-300. doi: 10.1093/brain/120.8.1279. Brain. 1997. PMID: 9278623
Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA, Kryzer TJ, Griesmann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH. Lennon VA, et al. N Engl J Med. 1995 Jun 1;332(22):1467-74. doi: 10.1056/NEJM199506013322203. N Engl J Med. 1995. PMID: 7739683
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L, Titulaer M, Saiz A, Verschuuren J, Güre AO, Graus F. Sabater L, et al. Neurology. 2008 Mar 18;70(12):924-8. doi: 10.1212/01.wnl.0000281663.81079.24. Epub 2007 Nov 21. Neurology. 2008. PMID: 18032743
[Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
Nakao Y, Motomura M, Suenaga A, Nakamura T, Yoshimura T, Tsujihata M, Ito M, Kono S, Eguchi K. Nakao Y, et al. Nihon Naika Gakkai Zasshi. 1998 Apr 10;87(4):685-90. Nihon Naika Gakkai Zasshi. 1998. PMID: 9627478 Review. Japanese. No abstract available.
[Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 1) The molecular structure of calcium channel and immunology].
Komai K, Iwasa K, Takamori M. Komai K, et al. Nihon Naika Gakkai Zasshi. 1998 Apr 10;87(4):678-84. Nihon Naika Gakkai Zasshi. 1998. PMID: 9627477 Review. Japanese. No abstract available.

See all similar articles

Cited by

Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases.
Boni C, Pagano M, Baldi L, Gnoni R, Braglia L, Savoldi L, Zanelli F. Boni C, et al. J Transl Med. 2015 Apr 24;13:130. doi: 10.1186/s12967-015-0491-3. J Transl Med. 2015. PMID: 25903963 Free PMC article.
The role of immunotherapy in small cell lung cancer.
Calles A, Aguado G, Sandoval C, Álvarez R. Calles A, et al. Clin Transl Oncol. 2019 Aug;21(8):961-976. doi: 10.1007/s12094-018-02011-9. Epub 2019 Jan 12. Clin Transl Oncol. 2019. PMID: 30637710 Review.
Chemo-immunotherapy as first-line treatment for small-cell lung cancer.
Farid S, Liu SV. Farid S, et al. Ther Adv Med Oncol. 2020 Dec 18;12:1758835920980365. doi: 10.1177/1758835920980365. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33414848 Free PMC article. Review.
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.
Arriola E, Wheater M, Galea I, Cross N, Maishman T, Hamid D, Stanton L, Cave J, Geldart T, Mulatero C, Potter V, Danson S, Woll PJ, Griffiths R, Nolan L, Ottensmeier C. Arriola E, et al. J Thorac Oncol. 2016 Sep;11(9):1511-21. doi: 10.1016/j.jtho.2016.05.028. Epub 2016 Jun 11. J Thorac Oncol. 2016. PMID: 27296105 Free PMC article. Clinical Trial.
Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.
Karabudak AA, Hafner J, Shetty V, Chen S, Secord AA, Morse MA, Philip R. Karabudak AA, et al. J Cancer Res Clin Oncol. 2013 Oct;139(10):1757-70. doi: 10.1007/s00432-013-1501-6. Epub 2013 Sep 3. J Cancer Res Clin Oncol. 2013. PMID: 23999876 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information